Старение. Профессиональный врачебный подход

   214. Van Voorhies W. A., Ward S. Genetic and environmental conditios that increase longevity in Caenorhabditis elegans decrease metabolic rate Proc. Natl. Acad. Sci. USA. 1999. Vol. 96. P. 11399–11403.

   215. Van Weel C., Schellevis F.G. Comorbidity and guidelines: conflicting interests // Lance t, 2006; 367:550-551

   216. Vasile E, Totnita K, Brown L F. etai. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis FASEB J. 2001. Vol. 15. P. 458–466.

   217. Vaupel J. W., Carey J. R., Christensen K. et ai Biodemographic trajectories of longevity Science. 1998. Vol. 280. P. 855–860.

   218. Vaupel J. W., Yashin A. I. Heterogeneity’s rises: some surprising effects of selection on population dynamics //Am. Stat. 1985. Vol.39. P. 176–185.

   219. Veda M. Telomerase in cutaneous carcinogenesis J. Dermatol. Sci. 2000. Vol. 23, Suppl 1. P. S37–S40.

   220. Velculescu V.E, Madden S.L., Zhang L. et al. Analysis of human transcrip-tomes Nat. Genet 1999. Vol. 23. P. 387–388.

   221. Verghese J., Holtzer R., Oh-Park M., Derby C.A., Lip ton R.B., Wang C. Inflammatory markers and gait speed decline in older adults. J Gerontol A Biol Sci Med Sci. 2011 Oct;66(10):1083-9. Epub 2011 Jun 30.

   222. Vijg J. Somatic mutations and aging: a re-evaluation Mutat. Res. 2000. Vol. 447. P. 117–135.

   223. Vijg J., Dolle M. E. T. Large genome rearrangements as a primary cause of aging Mech. Ageing Dev. 2002. Vol. 123. P. 907–915.

   224. Vkraintseva S.V., Yashin A.I. How individual age-associated changes may influence huma morbidity and mortality patterns Mech. Ageing Dev. 2001. Vol. 122. p. 1447–1460.

   225. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic and clinical implication for diabetes and aging Lab. Invest. 1994. Vol. 70. P. 138–151.

   226. Vleck С.M., Haussmann M.F., Vieck D. The natural history of telomere: tools for aging animals and exploring the aging process Exp. Gero ntol. 2003. Vol. 38. p. 791–795.

   227. Von Zglinicki T. Oxidative stress shortens telomeres Trends Biochem. Sci. 2002. Vol. 27. P. 339–344.

   228. Walter C. A., Grttbowski D.Т., Street K. A. et at. Analisys and modulation of DNA repair in aging // Mech. Ageing Dev. 1997. Vol. 98. P. 203–222.

   229. Walter L.C., Brand R.J., Counsell S.R., Palmer R.M., Landefeld C.S., Fortinsky R.H., Covinsky K.E. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization // JAMA, 2001; June 20; 285(23): 2987-94.

   230. Wamer H. ft., fngram D., Miller R.A. et al. Program for testing biological interventions to promote health aging Mech. Ageing Dev. 2000. Vol. 155. P. 199–208.

   231. Wang E. Regulation of apoptosis resistance and ontogeny of age-dependent diseases Exp. Gerontol. 1997. Vol. 32. P. 471–484.

   232. Wang J., Hannon G. J., Bea ch D. H. Risky immortalization by telomerase Nature. 2000. Vol. 405. P. 755–756.

   233. Wang P.S., Avorn J., Brookhart M.A. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives // Hypertension, 2005; 46(2):273–279.

   234. Warner H. R., Sierra F. Models of accelerated ageing can be informative about the molecular mechanisms of ageing and/or age-related pathology Mech. Ageing Dev. 2003. Vol. 124. In press.

   235. Walford R. L ITie Immunological Theory of Aging. Copenhagen: Muksgaard, 1969. 338 p.

   236. Wawruch M, Dukat A, Murin J, Wsolova L, Kuzelova M, Macugova A, Wimmer G Jr, Shah R. The effect of selected patient’s characteristics on the choice of antihypertensive medication in the elderly in Slovakia. Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1199-205.

   237. Weindruch R., Kayo Т., Lee C. K. Prolla T.A. Mkroarray profiling of gene expression in aging and its alteration by caloric restriction in mice J. Nutr. 2001. Vol. 13I.P. 918S–923S.

   238. Weismann A. Essays Upon Heredity and Kindred Biological Problems. Oxford: Claderon Press. 1889.

   239. Welle S. Gene transcript profiling in aging research. Exp. Gerontol. 2002. Vol. 37. P. 583–590.

   240. Wenger C. Multiple morbidity in a patient (87 years old). Praxis. 2001 Jan 18;90(3):75-8.

   241. WestendorpR. G, KirkwoodT. B. L. Human longevity at the cost of reproductive success Nature. 1998. Vol. 396. P. 743–746.

   242. Wet Q. Effect of aging on DNA repair and skin carcinogenesis: a minireview of population-based studies J. Investig.Dermatol.Symp. Proc. 1998. Vol.3, N 1. P. 19–22.

   243. Wien Klin Wochenschr. 2008;120(23–24):733-41.

   244. Wiklund O., Hulthe J., Wikstrand J., Schmidt C., Olofsson S-O., Bondjers G. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolem ia: a 3-year randomized study // Stroke 2002; 33: 572–577.

   245. Winter J. C. The effect of an extract of Ginkgo biloba, Egb 761, on cognnitive behavior and longevity in the rat Physiol. Behavior. 1998. Vol. 6. P. 425–433.